Highlights Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
79.58 ^USD	+5.52%		+22.56%	+327.62%

Apr. 25	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	MT
Apr. 24	Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	Apr. 25	MT
Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	Apr. 24	MT
Viking Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	Apr. 12	DJ
Health Care Down on Flight From Risk -- Health Care Roundup	Apr. 02	DJ
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	Apr. 01	DJ
Viking Therapeutics Reports 'Positive Results' in Study of Potential Obesity Drug; Shares Jump	Mar. 26	MT
PE firm Olympus to sell 9.8% stake in India's Aster DM Healthcare for up to $234.5 million, term sheet shows	Mar. 26	RE
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735	Mar. 26	CI
Health Care Up on Strong Earnings -- Health Care Roundup	Feb. 29	DJ
Global markets live: Reckitt, Apple, Warner, Eli Llily, Intel...	Feb. 28
Health Care Down as Viking Move Rattles Novo Shares -- Health Care Roundup	Feb. 27	DJ
News Highlights : Top Company News of the Day - Tuesday at 3 PM ET	Feb. 27	DJ
News Highlights : Top Company News of the Day - Tuesday at 1 PM ET	Feb. 27	DJ
Drugmakers deepen efforts to tap into booming market for obesity drugs	Feb. 27	RE
News Highlights : Top Company News of the Day - Tuesday at 11 AM ET	Feb. 27	DJ
News Highlights : Top Company News of the Day - Tuesday at 9 AM ET	Feb. 27	DJ
Viking Therapeutics' weight-loss drug succeeds in mid-stage study	Feb. 27	RE
Viking Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 07	CI
Roche enters obesity drugs race with $2.7 bln Carmot deal	Dec. 04	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Highlights

Filters